Leipzig-based BioTech startup enabling the sustainable and scalable manufacturing of complex, high-value molecules
Primogene has raised €4.1M across 1 funding round from 7 investors, most recently a Seed round in Apr 2026. Based in Leipzig, Germany; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-30 | Seed | €4.1M |
| Better Ventures,Dr. Marc Struhalla,FS Life Science Investment GmbH,Golzern Holding GmbH,High-Tech Gründerfonds (HTGF),Sächsische Beteiligungsgesellschaft (SBG)+1 more |
| View deal → |
